How are BRKR straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the BRKR straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 57.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$593.47 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a BRKR straddle?

The breakeven for the BRKR straddle priced on this page is roughly $53.78 and $66.23 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BRKR market-implied 1-standard-deviation expected move is approximately 16.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current BRKR implied volatility affect this straddle?

BRKR ATM IV is at 57.50% with IV rank near 36.72%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

BRKR Straddle Strategy

BRKR (Bruker Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography.

BRKR (Bruker Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $9.27B, a beta of 1.30 versus the broader market, a 52-week range of 28.53-64.54, average daily share volume of 2.4M, a public-listing history dating back to 2000, approximately 11K full-time employees. These structural characteristics shape how BRKR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.30 indicates BRKR has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. BRKR pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a straddle on BRKR?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current BRKR snapshot

As of June 29, 2026, spot at $59.39, ATM IV 57.50%, IV rank 36.72%, expected move 16.48%. The straddle on BRKR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this straddle structure on BRKR specifically: BRKR IV at 57.50% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 16.48% (roughly $9.79 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BRKR expiries trade a higher absolute premium for lower per-day decay. Position sizing on BRKR should anchor to the underlying notional of $59.39 per share and to the trader's directional view on BRKR stock.

BRKR straddle setup

The BRKR straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BRKR near $59.39, the first option leg uses a $60.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BRKR chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BRKR shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$60.00	$2.83
Buy 1	Put	$60.00	$3.40

BRKR straddle risk and reward

Net Premium / Debit: -$622.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$593.47
Breakeven(s): $53.78, $66.23
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

BRKR straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on BRKR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$5,376.50
$13.14	-77.9%	+$4,063.46
$26.27	-55.8%	+$2,750.43
$39.40	-33.7%	+$1,437.39
$52.53	-11.5%	+$124.36
$65.66	+10.6%	-$56.32
$78.79	+32.7%	+$1,256.71
$91.92	+54.8%	+$2,569.75
$105.05	+76.9%	+$3,882.78
$118.18	+99.0%	+$5,195.82

When traders use straddle on BRKR

Straddles on BRKR are pure-volatility plays that profit from large moves in either direction; traders typically buy BRKR straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

BRKR thesis for this straddle

The market-implied 1-standard-deviation range for BRKR extends from approximately $49.60 on the downside to $69.18 on the upside. A BRKR long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current BRKR IV rank near 36.72% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on BRKR should anchor more to the directional view and the expected-move geometry. As a Healthcare name, BRKR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BRKR-specific events.

BRKR straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BRKR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BRKR alongside the broader basket even when BRKR-specific fundamentals are unchanged. Always rebuild the position from current BRKR chain quotes before placing a trade.

Frequently asked questions

What is a straddle on BRKR?: A straddle on BRKR is the straddle strategy applied to BRKR (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With BRKR stock trading near $59.39, the strikes shown on this page are snapped to the nearest listed BRKR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are BRKR straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the BRKR straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 57.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$593.47 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a BRKR straddle?: The breakeven for the BRKR straddle priced on this page is roughly $53.78 and $66.23 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BRKR market-implied 1-standard-deviation expected move is approximately 16.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on BRKR?: Straddles on BRKR are pure-volatility plays that profit from large moves in either direction; traders typically buy BRKR straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current BRKR implied volatility affect this straddle?: BRKR ATM IV is at 57.50% with IV rank near 36.72%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.